170 related articles for article (PubMed ID: 6193454)
1. Actions of substance P, MIF, TRH and related peptides in the substantia nigra, caudate nucleus and nucleus accumbens.
Pinnock RD; Woodruff GN; Turnbull MJ
Neuropharmacology; 1983 Jun; 22(6):687-96. PubMed ID: 6193454
[TBL] [Abstract][Full Text] [Related]
2. Correlation of increased grooming behavior and motor activity with alterations in nigrostriatal and mesolimbic catecholamines after alpha-melanotropin and neuropeptide glutamine-isoleucine injection in the rat ventral tegmental area.
Sánchez MS; Barontini M; Armando I; Celis ME
Cell Mol Neurobiol; 2001 Oct; 21(5):523-33. PubMed ID: 11860189
[TBL] [Abstract][Full Text] [Related]
3. The effects of thyrotropin releasing hormone on rats with lesions of the mesolimbic and nigrostriatal dopamine systems.
Andrews JS; Sahgal A
Physiol Behav; 1985 Jul; 35(1):93-7. PubMed ID: 2997819
[TBL] [Abstract][Full Text] [Related]
4. Administration of thyrotropin releasing hormone (TRH) to rats releases dopamine in n. accumbens but not n. caudatus.
Heal DJ; Green AR
Neuropharmacology; 1979 Jan; 18(1):23-31. PubMed ID: 105304
[No Abstract] [Full Text] [Related]
5. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues.
Sharp T; Bennett GW; Marsden CA; Tulloch IF
Regul Pept; 1984 Nov; 9(4):305-15. PubMed ID: 6441196
[TBL] [Abstract][Full Text] [Related]
6. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
[TBL] [Abstract][Full Text] [Related]
7. Analogs of thyrotropin-releasing hormone in potentiating the spinal monosynaptic reflex in vitro.
Deshpande SB; Warnick JE
Eur J Pharmacol; 1994 Dec; 271(2-3):439-44. PubMed ID: 7705444
[TBL] [Abstract][Full Text] [Related]
8. [Effect of injection of thyrotropin-releasing hormone into nucleus accumbens on the pain discharges in nucleus parafascicularis of rat thalamus].
Nie Z; Liu Z
Zhen Ci Yan Jiu; 1990; 15(3):222-6. PubMed ID: 2125882
[TBL] [Abstract][Full Text] [Related]
9. Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system.
Kalivas PW; Stanley D; Prange AJ
Neuropharmacology; 1987 Jan; 26(1):33-8. PubMed ID: 3104814
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation by differential pulse voltammetry of the effect of thyrotropin-releasing hormone (TRH) on dopaminergic and serotoninergic synaptic activity in the striatum and nucleus accumbens of the rat.
Crespi F; Keane PE; Morre M
Exp Brain Res; 1986; 62(2):329-34. PubMed ID: 2423357
[TBL] [Abstract][Full Text] [Related]
11. Intracranial injection of thyrotropin releasing hormone (TRH) suppresses starvation-induced feeding and drinking in rats.
Suzuki T; Kohno H; Sakurada T; Tadano T; Kisara K
Pharmacol Biochem Behav; 1982 Aug; 17(2):249-53. PubMed ID: 6813881
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of affective aggression and dominance in rats after thyrotropin-releasing hormone (TRH) microinjection into the nucleus accumbens.
Puciłowski O; Trzaskowska E; Kostowski W; Wośko W
Peptides; 1988; 9(3):539-43. PubMed ID: 3138676
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of prolactin release in conscious sheep following stimulation of nucleus accumbens and caudate nucleus.
Malven PV
Neuroendocrinology; 1979; 28(3):160-8. PubMed ID: 106321
[No Abstract] [Full Text] [Related]
14. The functional role of the nucleus accumbens in the control of the substantia nigra: electrophysiological investigations in intact and striatum-globus pallidus lesioned rats.
Scarnati E; Campana E; Pacitti C
Brain Res; 1983 Apr; 265(2):249-57. PubMed ID: 6850328
[TBL] [Abstract][Full Text] [Related]
15. Pyroglutamyl-N3im-methyl-histidyl-prolineamide (methyl-thyrotrophin releasing hormone) in the rat hypothalamus.
Pekary AE; Morley JE; Hershman JM
J Endocrinol; 1978 Jun; 77(3):405-8. PubMed ID: 96203
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA-0910.
Yamamura M; Kinoshita K; Nakagawa H; Ishida R
Jpn J Pharmacol; 1991 Jan; 55(1):57-68. PubMed ID: 1904114
[TBL] [Abstract][Full Text] [Related]
17. Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats.
Miyamoto M; Nagawa Y
Eur J Pharmacol; 1977 Jul; 44(2):143-52. PubMed ID: 407089
[TBL] [Abstract][Full Text] [Related]
18. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
[TBL] [Abstract][Full Text] [Related]
19. Neurotropic and pituitary effects of melanostatin (MIF), thyroliberin (TRH) and structurally related peptides.
Björkman S
Acta Pharm Suec; 1980; 17(6):352. PubMed ID: 6111892
[No Abstract] [Full Text] [Related]
20. Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine.
Olds ME
Neuroscience; 1988 Feb; 24(2):465-76. PubMed ID: 3362349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
